Drug Shortage Report for PAMIDRONATE DISODIUM OMEGA 9 MG/ML

Last updated on 2025-05-02

Report ID 255294
Drug Identification Number 02249685
Brand name PAMIDRONATE DISODIUM OMEGA 9 MG/ML
Common or Proper name PAMIDRONATE DISODIUM
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) PAMIDRONATE DISODIUM
Strength(s) 9MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1 x 10 mL vial / fiole
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2025-06-01
Actual start date
Estimated end date 2025-07-31
Actual end date
Shortage status Anticipated shortage
Updated date 2025-05-02
Company comments We are currently collaborating with Health Canada’s Drug Shortages Unit to mitigate any market impact.
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information [email protected] - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2025-05-02 French Compare
v4 2025-05-02 English Compare
v3 2025-04-22 English Compare
v2 2025-04-21 French Compare
v1 2025-04-21 English Compare

Showing 1 to 5 of 5